Prevention, Complementary Therapies, and New Scientific Developments in the Field of Prostate Cancer

Por Kantoff, Philip
Publicado em 2006

Demystifying Immunotherapy in Prostate Cancer: Understanding Current and Future Treatment Strategies

Por Madan, Ravi A., Gulley, James L., Kantoff, Philip W.
Publicado em 2013

Contemporary Trends in Low-Risk Prostate Cancer: Risk Assessment and Treatment

Por Cooperberg, Matthew R., Broering, Jeannette M., Kantoff, Philip W., Carroll, Peter R.
Publicado em 2007

The role of microRNA-221 and -222 in Androgen-independent Prostate Cancer Cell lines

Por Sun, Tong, Wang, Qianben, Balk, Steven, Brown, Myles, Lee, Gwo-Shu Mary, Kantoff, Philip
Publicado em 2009

Prostate Cancer Immunotherapy

Por May, Kenneth F., Gulley, James L., Drake, Charles G., Dranoff, Glenn, Kantoff, Philip W.
Publicado em 2011

Emerging players in prostate cancer: long non-coding RNAs

Por Sun, Tong, Ye, Huihui, Wu, Chin-Lee, Lee, Gwo-Shu Mary, Kantoff, Philip W
Publicado no Am J Clin Exp Urol (2014)

Obesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate Cancer

Por Braunstein, Lior Z., Chen, Ming-Hui, Loffredo, Marian, Kantoff, Philip W., D'Amico, Anthony V.
Publicado em 2014

Prospective evaluation of analgesic use and risk of renal cell cancer

Por Cho, Eunyoung, Curhan, Gary, Hankinson, Susan E., Kantoff, Philip, Atkins, Michael B., Stampfer, Meir, Choueiri, Toni K.
Publicado em 2011

The CAG repeat within the androgen receptor gene and its relationship to prostate cancer

Por Giovannucci, Edward, Stampfer, Meir J., Krithivas, Krishna, Brown, Myles, Brufsky, Adam, Talcott, James, Hennekens, Charles H., Kantoff, Philip W.
Publicado em 1997

Inherited Variations in AR, ESR1, and ESR2 Genes Are Not Associated With Prostate Cancer Aggressiveness or With Efficacy of Androgen Deprivation Therapy

Por Sun, Tong, Lee, Gwo-Shu Mary, Werner, Lillian, Pomerantz, Mark, Oh, William K., Kantoff, Philip W., Freedman, Matthew L.
Publicado em 2010

Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo

Por Farokhzad, Omid C., Cheng, Jianjun, Teply, Benjamin A., Sherifi, Ines, Jon, Sangyong, Kantoff, Philip W., Richie, Jerome P., Langer, Robert
Publicado em 2006

Inherited Variants in the Chemokine CCL2 Gene and Prostate Cancer Aggressiveness in a Caucasian Cohort

Por Sun, Tong, Lee, Gwo-Shu Mary, Oh, William K., Freedman, Matthew L., Pomerantz, Mark, Pienta, Kenneth J., Kantoff, Philip W.
Publicado em 2010

Expression Differences of Circulating MicroRNAs in Metastastic Castration Resistant Prostate Cancer and Low-risk, Localized Prostate Cancer

Por Nguyen, Han Christine Ngoc, Xie, Wanling, Yang, Ming, Hsieh, Chen-Lin, Drouin, Sarah, Lee, Gwo-Shu Mary, Kantoff, Philip W.
Publicado em 2012

The DHEA-sulfate depot following P450c17 inhibition supports the case for AKR1C3 inhibition in high risk localized and advanced castration resistant prostate cancer

Por Tamae, Daniel, Mostaghel, Elahe, Montgomery, Bruce, Nelson, Peter S., Balk, Steven P., Kantoff, Philip W., Taplin, Mary-Ellen, Penning, Trevor M.
Publicado no Chem Biol Interact (2014)

Single-nucleotide Polymorphisms in p53 Pathway and Aggressiveness of Prostate Cancer in a Caucasian Population

Por Sun, Tong, Lee, Gwo-Shu Mary, Oh, William K., Pomerantz, Mark, Yang, Ming, Xie, Wanling, Freedman, Matthew L., Kantoff, Philip W.
Publicado em 2010

The Impact of Common Genetic Variations in Genes of the Sex Hormone Metabolic Pathways on Steroid Hormone Levels and Prostate Cancer Aggressiveness

Por Sun, Tong, Oh, William K., Jacobus, Susanna, Regan, Meredith, Pomerantz, Mark, Freedman, Matthew L., Mary Lee, Gwo-Shu, Kantoff, Philip W.
Publicado em 2011

Association of SLCO2B1 Genotypes With Time to Progression and Overall Survival in Patients Receiving Androgen-Deprivation Therapy for Prostate Cancer

Por Wang, Xiaodong, Harshman, Lauren C., Xie, Wanling, Nakabayashi, Mari, Qu, Fangfang, Pomerantz, Mark M., Lee, Gwo-Shu Mary, Kantoff, Philip W.
Publicado no J Clin Oncol (2016)

Androgen Receptor Mediates the Expression of UDP-Glucuronosyltransferase 2 B15 and B17 Genes

Por Bao, Bo-Ying, Chuang, Bin-Fay, Wang, Qianben, Sartor, Oliver, Balk, Steven P., Brown, Myles, Kantoff, Philip W., Lee, Gwo-Shu Mary
Publicado em 2008

Plasma Selenium, Manganese Superoxide Dismutase, and Intermediate- or High-Risk Prostate Cancer

Por Chan, June M., Oh, William K., Xie, Wanling, Regan, Meredith M., Stampfer, Meir J., King, Irena B., Abe, Miyako, Kantoff, Philip W.
Publicado em 2009

Single-nucleotide polymorphisms within the antioxidant defence system and associations with aggressive prostate cancer

Por Abe, Miyako, Xie, Wanling, Regan, Meredith M., King, Irena B., Stampfer, Meir J., Kantoff, Philip W., Oh, William K., Chan, June M.
Publicado em 2011